Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men-Reference-Cited by-同舟云学术

Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men

Published:2023-11-16 Issue:12 Volume:62 Page:1898-1904
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Siltari Aino¹²,Murtola Teemu J.¹³,Kausz Josefina¹,Talala Kirsi⁴,Taari Kimmo⁵,Tammela Teuvo LJ.¹³,Auvinen Anssi⁶

Affiliation:

1. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

2. Faculty of Medicine, Pharmacology, University of Helsinki, Helsinki, Finland

3. Department of Urology, Tampere University Hospital, Tampere, Finland

4. Finnish Cancer Registry, Helsinki, Finland

5. Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

6. Tampere University, Faculty of Social Sciences, Tampere, Finland

Funder

Academy of Finland

Cancer Foundation Finland

Finnish-Norwegian Medical Foundation

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2278189

Reference38 articles.

1. Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015

2. Adverse health effects of testosterone deficiency (TD) in men

3. Risks and benefits of testosterone therapy in older men

4. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease

5. Testosterone replacement therapy and cardiovascular risk

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives;Hormones;2024-07-26

2. Comment on: “Untreated hypogonadism and testosterone replacement therapy in hypogonadal men are associated with a decreased risk of subsequent prostate cancer: a population-based study”;International Journal of Impotence Research;2024-07-14